Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Gurruchaga

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pathologie-Biologie|April 1, 1992
[Platelets and migraine]H Ollat, J M Gurruchaga
Parkinsonism & Related Disorders|November 29, 2011
Changes in quality of life, burden and mood among spouses of Parkinson's disease patients receiving neurostimulationT Soulas, S Sultan, J-M Gurruchaga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 12, 2008
Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's diseaseT Soulas, J-M Gurruchaga, S Palfi, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 18, 2007
Subthalamic nucleus stimulation in Parkinson's disease: postoperative CT-MRI fusion images confirm accuracy of electrode placement using intraoperative multi-unit recordingM Shin, J-P Lefaucheur, M F Penholate, et al.
Revue Neurologique|May 10, 2016
Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson's disease having undergone DBS-STN: A validation studyT Soulas, M Storme, P Martínez-Martín, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 2, 2025
Deep brain stimulation is well tolerated and effective following ProSavin® gene therapy for Parkinson's diseaseS Senova, K Edakawa, G Gouello, et al.
European Journal of Neurology|September 30, 2017
High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 studyG Villafane, C Thiriez, E Audureau, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pathologie-Biologie|April 1, 1992
[Platelets and migraine]H Ollat, J M Gurruchaga
Parkinsonism & Related Disorders|November 29, 2011
Changes in quality of life, burden and mood among spouses of Parkinson's disease patients receiving neurostimulationT Soulas, S Sultan, J-M Gurruchaga, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|April 12, 2008
Attempted and completed suicides after subthalamic nucleus stimulation for Parkinson's diseaseT Soulas, J-M Gurruchaga, S Palfi, et al.
Neurophysiologie Clinique = Clinical Neurophysiology|December 18, 2007
Subthalamic nucleus stimulation in Parkinson's disease: postoperative CT-MRI fusion images confirm accuracy of electrode placement using intraoperative multi-unit recordingM Shin, J-P Lefaucheur, M F Penholate, et al.
Revue Neurologique|May 10, 2016
Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson's disease having undergone DBS-STN: A validation studyT Soulas, M Storme, P Martínez-Martín, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|July 2, 2025
Deep brain stimulation is well tolerated and effective following ProSavin® gene therapy for Parkinson's diseaseS Senova, K Edakawa, G Gouello, et al.
European Journal of Neurology|September 30, 2017
High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 studyG Villafane, C Thiriez, E Audureau, et al.
Pageof 1